Our new Cryptocurrency section has arrived! Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSareum Regulatory News (SAR)

Share Price Information for Sareum (SAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.465
Bid: 0.45
Ask: 0.48
Change: 0.04 (9.41%)
Spread: 0.03 (6.67%)
Open: 0.425
High: 0.485
Low: 0.42
Yest. Close: 0.425
SAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.
12
Date   Source Headline
20th Nov 20197:00 amRNSNotice of AGM
5th Nov 201910:56 amRNSSareum notes Sierra Oncology Q3 2019 results
30th Oct 20197:00 amRNSResearch Update - SDC-1802 anti-cancer poster
17th Oct 20197:00 amRNSResearch Update - AACR-NCI-EORTC abstract
15th Oct 20197:00 amRNSFinal Results
7th Oct 20197:00 amRNSNotice of Full Year Results
27th Sep 20197:00 amRNSResearch Update - TYK2/JAK1 cancer programme
27th Aug 20197:00 amRNSSareum Holdings PLC - Trading Statement
16th Aug 20197:00 amRNSSareum Holdings PLC - Change of Adviser
8th Aug 20192:17 pmRNSSareum Holdings PLC - Sareum notes Sierra Q2 results
29th Jul 20194:29 pmRNSSareum Holdings PLC - Additional disclosure concerning Michael Owen
28th Jun 20197:00 amRNSSareum Holdings PLC - Additional Funds Raised
27th Jun 20191:50 pmRNSSareum Holdings PLC - Sierra seeks strategic options for SRA737
26th Jun 20197:00 amRNSSareum Holdings PLC - Successful Fundraising
25th Jun 20194:31 pmRNSSareum Holdings PLC - PrimaryBid.com Offer
25th Jun 20194:30 pmRNSSareum Holdings PLC - Placing to progress TYK2/JAK1 programmes
13th Jun 20197:00 amRNSSareum Holdings PLC - Portfolio Update
3rd Jun 20194:00 pmRNSSareum Holdings PLC - Key takeaways from SRA737 webcast at ASCO
3rd Jun 201911:05 amRNSSareum Holdings PLC - Second Price Monitoring Extn
3rd Jun 201911:00 amRNSSareum Holdings PLC - Price Monitoring Extension
3rd Jun 20197:00 amRNSSareum Holdings PLC - Positive SRA737 data presented at ASCO
16th May 20197:00 amRNSSareum Holdings PLC - ASCO abstracts for SRA737 published
8th May 201912:41 pmRNSSareum Holdings PLC - Sareum notes Sierra Oncology Q1 2019 Results
30th Apr 20197:00 amRNSSareum Holdings PLC - Sareum to Present at BioTrinity 2019 in London
23rd Apr 20197:00 amRNSSareum Holdings PLC - SRA737 Phase I/IIa data to be presented at ASCO
2nd Apr 20197:00 amRNSSareum Holdings PLC - Preclinical Data for SRA737 Presented at AACR 2019
12th Mar 20197:00 amRNSSareum Holdings PLC - Sareum Holdings PLC Issue of Options
4th Mar 20197:00 amRNSSareum Holdings PLC - HALF-YEARLY RESULTS ENDED 31 DECEMBER 2018
28th Feb 20192:04 pmRNSSareum Holdings PLC - Sierra Oncology has reported its 2018 Results
28th Feb 20198:14 amRNSSareum Holdings PLC - New SRA737 preclin data to be presented at AACR
23rd Jan 20191:38 pmRNSSareum Holdings PLC - Sierra Oncology to present SRA737 at DDR Tx Summit
30th Nov 201811:17 amRNSSareum Holdings PLC - Amendment to Preclinical Efficacy Announcement
30th Nov 20187:45 amRNSSareum Holdings PLC - Preclinical Efficacy for Immunotherapy Combination
1st Oct 20187:00 amRNSSareum Holdings PLC - FINAL RESULTS FOR THE YEAR ENDED 30 JUNE 2018
27th Sep 20181:03 pmRNSSareum Holdings PLC - Notice of Results
26th Sep 20187:00 amRNSSareum Holdings PLC - TYK2/JAK1 selected for certain cancers
11th Sep 20187:00 amRNSSareum Holdings PLC - Pre-Close Trading Statement
10th Sep 20187:00 amRNSSareum Holdings PLC - Selection of TYK2/JAK1 for autoimmune diseases
9th Aug 20181:15 pmRNSSareum Holdings PLC - Sareum notes Sierra Oncology Q2 2018 Results
15th Jun 20187:00 amRNSSareum Holdings PLC - Advisers
31st May 20187:00 amRNSSareum Holdings PLC - Sareum regains rights to Aurora+FLT3 inhibitors
10th May 201812:21 pmRNSSareum Holdings PLC - SRA737 trial update in Sierra Oncology Q1 Results
15th Mar 20187:00 amRNSSareum Holdings PLC - Late-breaker abstract for SRA737 accepted for AACR
27th Feb 201812:50 pmRNSSierra Oncology expands SRA737 development program
22nd Feb 20187:00 amRNSPreclinical synergy of sra737 and PARP inhibitor
14th Dec 20177:00 amRNSAGM Statement
20th Nov 20177:00 amRNSNotice of AGM and Annual Report & Accounts
18th Sep 201712:00 pmRNSSierra Oncology to host call on Chk1 inhibitor
31st May 20177:00 amRNSSierra Oncology Granted US and EU Patents
25th May 20177:00 amRNSSierra Oncology to Present at ASCO Annual Meeting
12

Login to your account

Don't have an account? Click here to register.